Paradigm Biocapital Advisors LP - BICYCLE THERAPEUTICS PLC ownership

BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 101 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.8%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of BICYCLE THERAPEUTICS PLC
ValueSharesWeighting
Q1 2024$80,844,299
+20.6%
3,246,759
-12.4%
2.85%
-9.3%
Q4 2023$67,022,578
-8.4%
3,707,001
+1.8%
3.14%
-36.8%
Q3 2023$73,173,948
+44.4%
3,642,307
+83.5%
4.96%
+26.8%
Q2 2023$50,668,174
+31.1%
1,985,430
+9.3%
3.92%
+6.9%
Q1 2023$38,642,932
+5.9%
1,816,781
+47.3%
3.66%
-14.5%
Q4 2022$36,505,088
+35.4%
1,233,280
+6.4%
4.28%
+19.3%
Q3 2022$26,951,000
+53.2%
1,158,686
+10.5%
3.59%
+2.4%
Q2 2022$17,594,0001,048,5163.51%
Other shareholders
BICYCLE THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 967,347$20,575,47110.17%
Paradigm Biocapital Advisors LP 1,816,781$38,642,9323.66%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,408,831$29,965,8353.02%
Deep Track Capital, LP 2,819,045$59,961,0872.46%
Logos Global Management LP 750,000$15,952,5002.28%
HighVista Strategies LLC 92,434$1,966,0711.60%
First Light Asset Management, LLC 699,328$14,874,7071.34%
Ikarian Capital, LLC 207,112$4,405,2731.00%
Ikarian Capital, LLC 200,000$4,254,0000.96%
Soleus Capital Management, L.P. 411,800$8,758,9860.91%
View complete list of BICYCLE THERAPEUTICS PLC shareholders